These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16768750)

  • 1. Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis.
    Kay GW; Palmer DN; Rezaie P; Cooper JD
    Brain Pathol; 2006 Apr; 16(2):110-6. PubMed ID: 16768750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6).
    Oswald MJ; Palmer DN; Kay GW; Shemilt SJ; Rezaie P; Cooper JD
    Neurobiol Dis; 2005 Oct; 20(1):49-63. PubMed ID: 16137566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.
    Kay GW; Palmer DN
    J Neuroinflammation; 2013 Jul; 10():97. PubMed ID: 23899308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specific loss of GnRH-positive neurons from the hypothalamus of sheep with CLN6 neuronal ceroid lipofuscinosis occurs without glial activation and has only minor effects on reproduction.
    Kay GW; Jay NP; Palmer DN
    Neurobiol Dis; 2011 Mar; 41(3):614-23. PubMed ID: 21111820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease).
    Barry LA; Kay GW; Mitchell NL; Murray SJ; Jay NP; Palmer DN
    PLoS One; 2022; 17(4):e0261544. PubMed ID: 35404973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation.
    Tyynelä J; Cooper JD; Khan MN; Shemilts SJ; Haltia M
    Brain Pathol; 2004 Oct; 14(4):349-57. PubMed ID: 15605981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
    Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
    Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep.
    Pears MR; Salek RM; Palmer DN; Kay GW; Mortishire-Smith RJ; Griffin JL
    J Neurosci Res; 2007 Nov; 85(15):3494-504. PubMed ID: 17510975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis.
    Lange J; Haslett LJ; Lloyd-Evans E; Pocock JM; Sands MS; Williams BP; Cooper JD
    Acta Neuropathol Commun; 2018 Aug; 6(1):74. PubMed ID: 30089511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.
    Murray SJ; Russell KN; Melzer TR; Gray SJ; Heap SJ; Palmer DN; Mitchell NL
    Exp Eye Res; 2021 Jun; 207():108600. PubMed ID: 33930398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses.
    Russell KN; Mitchell NL; Anderson NG; Bunt CR; Wellby MP; Melzer TR; Barrell GK; Palmer DN
    Brain Behav; 2018 Sep; 8(9):e01096. PubMed ID: 30136763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis.
    Kanninen KM; Grubman A; Meyerowitz J; Duncan C; Tan JL; Parker SJ; Crouch PJ; Paterson BM; Hickey JL; Donnelly PS; Volitakis I; Tammen I; Palmer DN; White AR
    PLoS One; 2013; 8(3):e58644. PubMed ID: 23516525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.
    Kuronen M; Lehesjoki AE; Jalanko A; Cooper JD; Kopra O
    Neurobiol Dis; 2012 Sep; 47(3):444-57. PubMed ID: 22569358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis.
    Murray SJ; Almuqbel MM; Felton SA; Palmer NJ; Myall DJ; Shoorangiz R; Ella A; Keller M; Palmer DN; Melzer TR; Mitchell NL
    Brain Commun; 2023; 5(1):fcac339. PubMed ID: 36632184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).
    Kay GW; Verbeek MM; Furlong JM; Willemsen MA; Palmer DN
    Neurochem Int; 2009 Dec; 55(8):783-8. PubMed ID: 19664668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging.
    Sawiak SJ; Perumal SR; Rudiger SR; Matthews L; Mitchell NL; McLaughlan CJ; Bawden CS; Palmer DN; Kuchel T; Morton AJ
    PLoS One; 2015; 10(7):e0132331. PubMed ID: 26161747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis.
    Bartsch U; Galliciotti G; Jofre GF; Jankowiak W; Hagel C; Braulke T
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6952-9. PubMed ID: 24084090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal ceroid lipofuscinoses: the same, but different?
    Cooper JD
    Biochem Soc Trans; 2010 Dec; 38(6):1448-52. PubMed ID: 21118105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.